SHH and medulloblastoma: Pediatric SHH medulloblastoma patients should undergo genetic counselling for evaluation of germline TP53 and SHH pathway mutations (Gorlin syndrome) and WNT patients without somatic CTNNB1 mutations require genetic counselling for APC sequencing.